Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Donepezil/nebivolol - DR.NOAH Biotech

Next Previous
Drug Profile

Donepezil/nebivolol - DR.NOAH Biotech

Alternative Names: NDC-011; nebivolol/donepezil

Latest Information Update: 09 Jan 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator DR.NOAH Biotech
  • Class Antidementias; Antihypertensives; Benzopyrans; Ethanolamines; Fluorobenzenes; Heart failure therapies; Indans; Nootropics; Piperidines; Small molecules
  • Mechanism of Action Acetylcholinesterase inhibitors; Beta 1 adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Amyotrophic lateral sclerosis
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Amyotrophic lateral sclerosis

Most Recent Events

  • 18 Sep 2025 Preclinical trials in Amyotrophic lateral sclerosis in South Korea (PO), Prior to September 2025 (DR.NOAH Biotech pipeline, September 2025)
  • 18 Sep 2025 DR.NOAH Biotech plans to initiate a phase II trial in 2026
  • 31 Dec 2024 DR.NOAH Biotech received Investigational New Drug (IND) approval for a Phase I clinical trial in 2024 (DR.NOAH Biotech pipeline, September 2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top